Home  »  Technologies   »  Elanco Animal Health Incorporated (ELAN) Is A Buy ...

Elanco Animal Health Incorporated (ELAN) Is A Buy According To Analysts

Elanco Animal Health Incorporated (NYSE:ELAN) has a beta value of 0.86 and has seen 6.83 million shares traded in the last trading session. The company, currently valued at $6.72B, closed the last trade at $13.85 per share which meant it lost -$0.64 on the day or -4.42% during that session. The ELAN stock price is -152.71% off its 52-week high price of $35.00 and -0.65% below the 52-week low of $13.94. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.44 million shares traded. The 3-month trading volume is 6.32 million shares.

Elanco Animal Health Incorporated (NYSE:ELAN) trade information

Sporting -4.42% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 09/20/22 when the ELAN stock price touched $13.85 or saw a rise of 11.9%. Year-to-date, Elanco Animal Health Incorporated shares have moved -51.20%, while the 5-day performance has seen it change -9.89%. Over the past 30 days, the shares of Elanco Animal Health Incorporated (NYSE:ELAN) have changed -20.72%. Short interest in the company has seen 14.74 million shares shorted with days to cover at 3.09.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored

Elanco Animal Health Incorporated (ELAN) estimates and forecasts

Figures show that Elanco Animal Health Incorporated shares have outperformed across the wider relevant industry. The company’s shares have lost -49.08% over the past 6 months, with this year growth rate of 4.76%, compared to -11.20% for the industry. Other than that, the company has, however, increased its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are -7.10% and 36.80% for the next quarter. Revenue growth from the last financial year stood is estimated to be -1.40%.

9 analysts offering their estimates for the company have set an average revenue estimate of $1.18 billion for the current quarter. 9 have an estimated revenue figure of $1.14 billion for the next quarter concluding in Sep 2022. Year-ago sales stood $1.28 billion and $1.08 billion respectively for this quarter and the next, and analysts expect sales will shrink by -7.50% for the current quarter and 5.60% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -48.40% over the past 5 years. Earnings growth for 2022 is a modest 23.70% while over the next 5 years, the company’s earnings are expected to increase by 13.00%.

ELAN Dividends

Elanco Animal Health Incorporated is expected to release its next earnings report between February 22 and February 28 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Elanco Animal Health Incorporated (NYSE:ELAN)’s Major holders

Insiders own 4.13% of the company shares, while shares held by institutions stand at 107.00% with a share float percentage of 111.61%. Investors are also buoyed by the number of investors in a company, with Elanco Animal Health Incorporated having a total of 672 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 41.45 million shares worth more than $1.08 billion. As of Mar 30, 2022, Vanguard Group, Inc. (The) held 8.74% of shares outstanding.

The other major institutional holder is Price (T.Rowe) Associates Inc, with the holding of over 34.51 million shares as of Mar 30, 2022. The firm’s total holdings are worth over $900.45 million and represent 7.28% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Dodge & Cox Stock Fund and Vanguard/Primecap Fund. As of Jun 29, 2022, the former fund manager holds about 7.38% shares in the company for having 35.0 million shares of worth $687.01 million while later fund manager owns 13.56 million shares of worth $353.88 million as of Mar 30, 2022, which makes it owner of about 2.86% of company’s outstanding stock.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]